A peanut patch immunotherapy demonstrated efficacy and safety in desensitizing young children with peanut allergy in a phase 3 study.

DBV Technologies SA said its experimental skin patch helped young children with a peanut allergy in a crucial study.

DBV Technologies is headquartered in Châtillon, France, with North American operations in Warren, NJ. The Company’s ordinary ...

DBV Technologies patch treatment for children allergic to peanuts met its primary endpoint in a Phase 3 trial. The biopharmaceutical company said Tuesday 46.6% of children who used the patch, named ...

Shares in the company rose more than 35% on the strength of the data, which could put DBV on track to bring the immunotherapy ...

VIASKIN patch is designed to introduce microgram amounts of an allergen like peanuts to the immune system through intact skin ...

DBV Technologies recently reported that its pivotal Phase 3 VITESSE trial of the Viaskin Peanut patch in children aged 4–7 met its primary endpoint with statistically significant desensitization and a ...

Awake offered more; 50 milligrams of wake-up chemicals in a half-ounce serving. Two of those bites, the packaging reasons, ...

The article 🌱 Patch AM: How is Eagan rallying after a devastating church fire? appeared first on Eagan Patch. Hey there, Eagan! Let's get started with what's happening in and around town. Read on and ...

Châtillon, France, December 16, 2025 DBV Technologies Announces Positive Topline Results from Phase 3 VITESSE Trial of VIASKIN Peanut Patch in Peanut Allergic Children Aged 4-7 Years VITESSE ...

America seems to be craving nostalgic classics this holiday season! Take a look at the top trending Christmas cookies of 2025 ...

This 60th anniversary zoetrope vinyl of A Charlie Brown Christmas delivers animated fun, solid sound, and a perfect last-minute gift for jazz fans.